Can I read CRISPR-Cas9 Gene Editing in Treatable Cardiomyopathies - Current Delivery Vehicles and Off-Target Risks on EtoBox?

CRISPR-Cas9 Gene Editing in Treatable Cardiomyopathies - Current Delivery Vehicles and Off-Target Risks by vomanhcuong2010 is a document available to read on EtoBox.

What is CRISPR-Cas9 Gene Editing in Treatable Cardiomyopathies - Current Delivery Vehicles and Off-Target Risks about?

CRISPR-Cas9 gene editing presents a potential therapeutic approach for inherited cardiomyopathies by directly addressing genetic mutations. Key challenges include effective delivery to cardiac cells and minimizing off-target effects, with current research focusing on both viral and non-viral delivery methods. Advances in bioengineering, such as high-fidelity Cas9 variants and transient delivery systems, aim to enhance the safety and precision of these therapies for clinical use.

Author

vomanhcuong2010

Language

EN